UPC: what’s in store?

Drug companies are scared of it and are likely to steer clear of it. It is too risky and there is too much to lose. This could be how some pharmaceutical companies view the Unified Patent Court (UPC) and the unitary patent, a new system in 25 EU member states that is likely to come into force in 2017.